ROLE OF MONTELUKAST IN PREVENTING RELAPSE IN CHILDHOOD IDIOPATHIC NEPHROTIC SYNDROME: A QUASI-EXPERIMENTAL STUDY
Open Access
- 30 June 2021
- journal article
- research article
- Published by Khyber Medical University in Khyber Medical University Journal
- Vol. 13 (2), 66-70
- https://doi.org/10.35845/kmuj.2021.20903
Abstract
OBJECTIVE: To study the role of montelukast in preventing relapses in childhood idiopathic steroid sensitive nephrotic syndrome (SSNS). METHODS: This quasi-experimental, open label study was conducted at Department of Paediatric Nephrology, The Children’s Hospital and The Institute of Child Health, Multan, Pakistan. Total of 106 patients with first-episode of nephrotic syndrome, aged 1-10 years were enrolled from February-May 2019 and non-randomly assigned to Group-A & Group-B (53 patients in each group). All patients in both groups were started on prednisolone 2mg/kg single morning dose for 4-weeks as per institutional protocol. Group-A (Cases) also received montelukast 5mg daily at bedtime for at least 12 months while Group-B (control) was not given montelukast. All patients were followed up for one year till May 2020 to monitor the response to treatment and evidence of relapse. Ten patients were excluded from final analysis due to loss to follow-up (n=3; 2 in Group-A and 1 in Group-B) or showing steroids resistance (n=7; 3 in Group-A and 4 in Group-B). RESULTS: Out of 96 children (48 each in Group-A & B), 58 (60.4%) were males. Mean age was 4.7±1.9 years and most of children (n=64; 66.7%), were aged between 2-6 years. Overall relapse rate of 35.4% (n=34/98) was observed, with 9/48 (18.8%) patients in Group-A compared to 25/48 (52.1%) patients in Group-B (pCONCLUSION: Montelukast showed significant efficacy in preventing relapse rate in children with SSNS during one year of follow-up.Keywords
This publication has 13 references indexed in Scilit:
- Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trialJournal of Nephrology, 2016
- Pathology of Podocytopathies Causing Nephrotic Syndrome in ChildrenFrontiers in Pediatrics, 2016
- Effects of Interleukin-13 and Montelukast on the Expression of Zonula Occludens-1 in Human PodocytesYonsei Medical Journal, 2015
- Montelukast: a novel therapeutic option in eosinophilic peritonitisPediatric Nephrology, 2013
- Cough, asthma, and cysteinyl-leukotrienesPulmonary Pharmacology & Therapeutics, 2013
- Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal diseaseBrazilian Journal of Nephrology, 2013
- Revised guidelines for management of steroid-sensitive nephrotic syndromeIndian Journal of Nephrology, 2008
- Overexpression of Interleukin-13 Induces Minimal-Change–Like Nephropathy in RatsJournal of the American Society of Nephrology, 2007
- Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change diseaseNephrology Dialysis Transplantation, 2005
- Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndromePediatric Nephrology, 2004